Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

An application of a Hill-based response surface model for a drug combination experiment on lung cancer.

Ning S, Xu H, Al-Shyoukh I, Feng J, Sun R.

Stat Med. 2014 Oct 30;33(24):4227-36. doi: 10.1002/sim.6229. Epub 2014 Jun 18.

3.
4.

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.

Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.

Cancer Chemother Pharmacol. 2008 Sep;62(4):621-9. Epub 2007 Nov 24.

PMID:
18038274
5.

In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.

Webb MS, Johnstone S, Morris TJ, Kennedy A, Gallagher R, Harasym N, Harasym T, Shew CR, Tardi P, Dragowska WH, Mayer LD, Bally MB.

Eur J Pharm Biopharm. 2007 Mar;65(3):289-99. Epub 2006 Oct 17.

PMID:
17123800
6.

Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer.

Daga H, Takeda K, Okada H, Miyazaki M, Ueda S, Kaneda H, Okamoto I, Yoh K, Goto K, Konishi K, Sarashina A, Tanaka T, Kaiser R, Nakagawa K.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1225-33. doi: 10.1007/s00280-015-2896-3. Epub 2015 Nov 11.

PMID:
26560486
7.
8.
9.

Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.

Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.

Clin Cancer Res. 2000 May;6(5):2075-86.

10.

Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.

Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL.

Cochrane Database Syst Rev. 2014 Nov 17;(11):CD009948. doi: 10.1002/14651858.CD009948.pub2. Review.

PMID:
25400254
11.

Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.

Vandana M, Sahoo SK.

Eur J Pharm Biopharm. 2015 Aug;94:83-93. doi: 10.1016/j.ejpb.2015.04.017. Epub 2015 May 9.

PMID:
25968494
12.

Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.

Jin H, Yang R, Ross J, Fong S, Carano R, Totpal K, Lawrence D, Zheng Z, Koeppen H, Stern H, Schwall R, Ashkenazi A.

Clin Cancer Res. 2008 Dec 1;14(23):7733-40. doi: 10.1158/1078-0432.CCR-08-0670.

13.

A simple test for synergy for a small number of combinations.

Novick SJ.

Stat Med. 2013 Dec 20;32(29):5145-55. doi: 10.1002/sim.5905. Epub 2013 Aug 1.

PMID:
23904140
15.
16.

Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.

Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.

Clin Cancer Res. 1999 Jul;5(7):1905-17.

17.

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.

Rebattu P, Quantin X, Ardiet C, Morere JF, Azarian MR, Schuller-Lebeau MP, Pujol JL.

Lung Cancer. 2001 Aug-Sep;33(2-3):277-87.

PMID:
11551423
18.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
19.

Phase I/II study of amrubicin in combination with S-1 as second-line chemotherapy for non-small-cell lung cancer without EGFR mutation.

Murakami S, Oshita F, Sugiura M, Kondo T, Saito H, Yamada K.

Cancer Chemother Pharmacol. 2013 Mar;71(3):705-11. doi: 10.1007/s00280-012-2061-1. Epub 2013 Jan 18.

PMID:
23328865
20.

Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non-small cell lung cancer patients.

Ellis PM, Kaiser R, Zhao Y, Stopfer P, Gyorffy S, Hanna N.

Clin Cancer Res. 2010 May 15;16(10):2881-9. doi: 10.1158/1078-0432.CCR-09-2944. Epub 2010 May 11.

Supplemental Content

Support Center